Market Indices
Sector Heatmap
NAGE — Niagen Bioscience, Inc. Common Stock
NasdaqNiagen Bioscience, Inc. Common Stock
- O
- 2.67
- H
- 2.71
- L
- 2.66
- V
- 368.31K
NAGE — Latest News & Headlines
9 StoriesNiagen Bioscience, Inc. (NAGE) stock price, news, quote and history - Yahoo Finance UK
Niagen Bioscience, Inc. (NAGE) stock price, news, quote and history Yahoo Finance UK
A healthy-aging research company’s CEO is set to speak in Los Angeles Oct. 21. - Stock Titan
A healthy-aging research company’s CEO is set to speak in Los Angeles Oct. 21. Stock Titan
Niagen Bioscience: Down 68%, But Still Not Quite A Buy (NASDAQ:NAGE) - Seeking Alpha
Niagen Bioscience: Down 68%, But Still Not Quite A Buy (NASDAQ:NAGE) Seeking Alpha
Transcript: Niagen Bioscience Q2 2026 Earnings Conference Call - Benzinga
Transcript: Niagen Bioscience Q2 2026 Earnings Conference Call Benzinga
At 54, 11-time surfing champion Kelly Slater still competes—and fronts Niagen's new campaign. - Stock Titan
At 54, 11-time surfing champion Kelly Slater still competes—and fronts Niagen's new campaign. Stock Titan
Canaccord reiterates Niagen stock rating on healthy aging strategy - Investing.com
Canaccord reiterates Niagen stock rating on healthy aging strategy Investing.com
Niagen Bioscience, Inc. Begins Detailed Planning with Mass General Brigham for Healthy Aging Clinical Trial Evaluating Niagen Supplementation - www.marketscreener.com
Niagen Bioscience, Inc. Begins Detailed Planning with Mass General Brigham for Healthy Aging Clinical Trial Evaluating Niagen Supplementation www.marketscreener.com
Niagen Bioscience (NAGE): Can Its NAD+ Business Drive the Next Leg of Growth? - Yahoo Finance
Niagen Bioscience (NAGE): Can Its NAD+ Business Drive the Next Leg of Growth? Yahoo Finance
Niagen Bioscience signs agreement for clinical trial planning By Investing.com - Investing.com India
Niagen Bioscience signs agreement for clinical trial planning By Investing.com Investing.com India